Abiopharma

New Form 8-K - ARVINAS, INC. Filed: 2025-06-13 AccNo: 0001655759-25-000103 Size: 1 MB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 6-K - NOVO NORDISK A S Filed: 2025-06-13 AccNo: 0001171843-25-003877 Size: 162 KB

New Form 8-K - Tonix Pharmaceuticals Holding Corp. Filed: 2025-06-13 AccNo: 0001999371-25-007734 Size: 232 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 6-K - GH Research PLC Filed: 2025-06-13 AccNo: 0001140361-25-022373 Size: 8 KB

New Form 6-K - Quantum Biopharma Ltd. Filed: 2025-06-13 AccNo: 0001171843-25-003876 Size: 20 KB

New Form 6-K - GSK plc Filed: 2025-06-13 AccNo: 0001654954-25-006893 Size: 38 KB

New Form S-3MEF - Enliven Therapeutics, Inc. Filed: 2025-06-13 AccNo: 0001193125-25-140305 Size: 105 KB

New Form 424B5 - Catheter Precision, Inc. Filed: 2025-06-13 AccNo: 0001437749-25-020252 Size: 16 KB

New Form 8-K - Catheter Precision, Inc. Filed: 2025-06-13 AccNo: 0001437749-25-020251 Size: 200 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 40-17F2 - DAXOR CORP Filed: 2025-06-13 AccNo: 0001641172-25-014960 Size: 73 KB